FDG-PET Follow-up of Non-Small Cell Lung Cancer: Not Dead Yet

被引：3
|
作者：
Stirling, Rob G. [1 ]
Zalcberg, John [1 ]
机构：
[1] Monash Univ, Dept Epidemiol & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia
来源：
ANNALS OF THORACIC SURGERY | 2020年 / 109卷 / 05期
关键词：
D O I：
10.1016/j.athoracsur.2019.05.042
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1624 / 1624
页数：1
相关论文
共 50 条
  • [21] Diagnostic and prognostic values of FDG-PET in patients with non-small cell lung cancer
    Abe, Koichiro
    Baba, Shingo
    Kaneko, Koichiro
    Isoda, Takuro
    Yabuuchi, Hidetake
    Sasaki, Masayuki
    Sakai, Shuji
    Yoshino, Ichiro
    Honda, Hiroshi
    CLINICAL IMAGING, 2009, 33 (02) : 90 - 95
  • [22] FDG-PET BASED CHEMOTHERAPY SELECTION FOR METASTATIC NON-SMALL CELL LUNG CANCER
    Eaton, Keith
    Martins, Renato G.
    Guthrie, Katherine A.
    Stricker, Kari
    Leblond, Antoine
    Carr, Laurie L.
    Umlauf, Jon
    Vesselle, Hubert
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S353 - S354
  • [23] A Feasible Follow-Up Program Using FDG-PET/CT for Asymptomatic Postoperative Non-Small-Cell Lung Cancer Patients
    Toba, H.
    Kawakita, N.
    Sawada, T.
    Tsuboi, M.
    Takizawa, H.
    Kondo, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2318 - S2318
  • [24] (18)FDG-PET metabolic response of non-small-cell lung cancer to chemoradiotherapy with long-term follow-up
    Ampil, Federico
    Caldito, Gloria
    Richards, Troy
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2018, 17 (01) : 131 - 134
  • [25] The role of FDG-PET in the management of non-small cell lung carcinoma
    Shon, IH
    Maisey, MN
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2004, 33 (02) : 166 - 174
  • [26] Postoperative Follow-Up for Patients with Non-Small Cell Lung Cancer
    Nakamura, Ryota
    Kurishima, Koichi
    Kobayashi, Naohiro
    Ishikawa, Shigemi
    Goto, Yukinobu
    Sakai, Mitsuaki
    Onizuka, Masataka
    Ishikawa, Hiroichi
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    Sato, Yukio
    ONKOLOGIE, 2010, 33 (1-2): : 14 - 18
  • [27] FDG-PET SUVmax Does Not Correlate with Glucose Metabolism in Non-Small Cell Lung Cancer
    Kernstine, Kemp
    Faubert, Brandon
    Hensley, Christopher
    Cai, Ling
    Torrealba, Jose
    Oliver, Dwight
    Lenkinski, Robert
    Malloy, Craig
    Deberardinis, Ralph
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S554 - S554
  • [28] Pretreatment prediction of prognosis by FDG-PET in patients with non-small cell lung cancer.
    Sasaki, M
    Kuwabara, Y
    Koga, H
    Nakagawa, M
    Hayashi, K
    Kaneko, K
    Chen, T
    Masuda, K
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 301P - 301P
  • [29] FDG-PET and CT features of non-small cell lung cancer based on tumor type
    Aquino, Suzanne L.
    Halpern, Elkan F.
    Kuester, Landon B.
    Fischman, Alan J.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 19 (03) : 495 - 499
  • [30] Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer
    Sunaga, Noriaki
    Oriuchi, Noboru
    Kaira, Kyoichi
    Yanagitani, Noriko
    Tomizawa, Yoshio
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Endo, Keigo
    Mori, Masatomo
    LUNG CANCER, 2008, 59 (02) : 203 - 210
12345